NeoGenomics
NEO
#5166
Rank
โ‚น137.52 B
Marketcap
โ‚น1,063
Share price
-2.93%
Change (1 day)
-30.33%
Change (1 year)

Revenue for NeoGenomics (NEO)

Revenue in 2025 (TTM): โ‚น61.34 Billion

According to NeoGenomics 's latest financial reports the company's current revenue (TTM ) is โ‚น63.79 Billion. In 2024 the company made a revenue of โ‚น56.66 Billion an increase over the revenue in the year 2023 that were of โ‚น49.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NeoGenomics from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น61.34 B8.25%
2024 โ‚น56.66 B15.05%
2023 โ‚น49.25 B16.77%
2022 โ‚น42.18 B17.01%
2021 โ‚น36.04 B10.91%
2020 โ‚น32.50 B11.49%
2019 โ‚น29.15 B50.66%
2018 โ‚น19.35 B22.88%
2017 โ‚น15.74 B-5.06%
2016 โ‚น16.58 B150.09%
2015 โ‚น6.63 B20.19%
2014 โ‚น5.51 B34.38%
2013 โ‚น4.10 B25.27%
2012 โ‚น3.27 B42.5%
2011 โ‚น2.30 B49.35%
2010 โ‚น1.54 B12.64%
2009 โ‚น1.36 B42.13%
2008 โ‚น0.96 B113.07%
2007 โ‚น0.45 B57.42%
2006 โ‚น0.28 B238.08%
2005 โ‚น84.83 M251.03%
2004 โ‚น24.16 M43.48%
2003 โ‚น16.84 M
2000 โ‚น11.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
RadNet
RDNT
โ‚น177.18 B 177.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚น1.77 B-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น976.06 B 1,429.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1.238 T 1,841.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น2.47 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA